Mutational induction in SARS-CoV-2 major lineages by experimental exposure to neutralising sera

© 2022. The Author(s)..

The ongoing evolution of SARS-CoV-2 and the emergence of new viral variants bearing specific escape mutations responsible for immune evasion from antibody neutralisation has required a more accurate characterisation of the immune response as one of the evolutive forces behind viral adaptation to a largely immunised human population. In this work, culturing in the presence of neutralising sera vigorously promoted mutagenesis leading to the acquisition of known escape mutations on the spike as well as new presumptive escape mutations on structural proteins whose role as target of the neutralizing antibody response might have been thus far widely neglected. From this perspective, this study, in addition to tracing the past evolution of the species back to interactions with neutralising antibody immune response, also offers a glimpse into future evolutive scenarios.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:12

Enthalten in:

Scientific reports - 12(2022), 1 vom: 21. Juli, Seite 12479

Sprache:

Englisch

Beteiligte Personen:

Brandolini, Martina [VerfasserIn]
Dirani, Giorgio [VerfasserIn]
Taddei, Francesca [VerfasserIn]
Zannoli, Silvia [VerfasserIn]
Denicolò, Agnese [VerfasserIn]
Arfilli, Valentina [VerfasserIn]
Battisti, Arianna [VerfasserIn]
Manera, Martina [VerfasserIn]
Mancini, Andrea [VerfasserIn]
Grumiro, Laura [VerfasserIn]
Marino, Maria Michela [VerfasserIn]
Gatti, Giulia [VerfasserIn]
Fantini, Michela [VerfasserIn]
Semprini, Simona [VerfasserIn]
Sambri, Vittorio [VerfasserIn]

Links:

Volltext

Themen:

Antibodies, Neutralizing
Antibodies, Viral
Journal Article
Spike Glycoprotein, Coronavirus
Spike protein, SARS-CoV-2

Anmerkungen:

Date Completed 25.07.2022

Date Revised 16.09.2023

published: Electronic

Citation Status MEDLINE

doi:

10.1038/s41598-022-16533-4

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM343842041